Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-43,321
Closed -$3.64M 289
2017
Q3
$3.64M Sell
43,321
-12
-0% -$851 0.37% 63
2017
Q2
$2.83M Sell
43,333
-357
-0.8% -$24.3K 0.3% 68
2017
Q1
$3.17M Sell
43,690
-1,306
-3% -$85.8K 0.34% 66
2016
Q4
$2.64M Buy
+44,996
New +$2.38M 0.29% 72

Other funds holding ADNT

Shufro Rose & Co's ADNT Position: Q4 2017 in Review

Shufro Rose & Co sold out of Adient (ADNT) in Q4 2017, closing a stake of 43,321 shares — an estimated $3.64M sold.

Shufro Rose & Co first reported a position in ADNT in Q4 2016 and held it in 4 quarters. The position peaked at $3.64M in Q3 2017. 449 funds tracked by Wall St. Rank hold ADNT as of Q4 2017.

  • Shufro Rose & Co reported no remaining Adient position as of Q4 2017 after selling out during the quarter.
  • Shufro Rose & Co sold 43,321 Adient shares in Q4 2017, an estimated $3.64M.
  • Shufro Rose & Co first reported a position in Adient in Q4 2016 and held it in 4 quarters.
  • Shufro Rose & Co's Adient position peaked at $3.64M in Q3 2017.
  • 449 funds tracked by Wall St. Rank held Adient as of Q4 2017.

Based on Shufro Rose & Co's 13F filing for Q4 2017, filed 6 Feb 2018.